Atossa Therapeutics (ATOS) Change in Accrued Expenses (2009 - 2026)
Atossa Therapeutics (ATOS) recorded Change in Accured Expenses of -$2.09 million in Q2 2026, compared with $2.2 million a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
On a TTM basis, Atossa Therapeutics' Change in Accured Expenses came in at -$1.48 million as of Jun 30, 2026; for FY2025, it was $388,000, up 86.5% from FY2024.
- Annual Change in Accured Expenses has a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
- Across earlier years, Change in Accured Expenses came in at $208,000 in FY2024 (+61.2%), $129,000 in FY2023 (-84.9%), $855,000 in FY2022 (+288.6%) and $220,000 in FY2021 (+243.8%).
- The Q2 2026 figure is the lowest quarterly Change in Accured Expenses in data going back to Q4 2011.
- Per Business Quant, the preceding three quarters came in at $1.5 million (Q1 2026), -$682,000 (Q4 2025) and -$211,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Atossa Therapeutics | 21.38 Mn | -98.31 Mn | - | 195,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 195,000.00 |
| Jun 30, 2026 | -2.09 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | -682,000.00 |
| Sep 30, 2025 | -211,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | -920,000.00 |
| Dec 31, 2024 | -513,000.00 |
| Sep 30, 2024 | -213,000.00 |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | -995,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Sep 30, 2023 | 458,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | -703,000.00 |
| Dec 31, 2022 | 968,000.00 |
| Sep 30, 2022 | -743,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | -591,000.00 |
| Dec 31, 2021 | 271,000.00 |
API Access
Atossa Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();